Andrea L.C. Reid

andrea-reid

Andrea L.C. Reid

Partner

Boston | One International Place, 40th Floor, 100 Oliver Street, Boston, MA, United States of America 02110-2605
+1 617 728 7131 | +1 617 426 6567

| vCard | PDF

Andrea L.C. Reid, co-lead of Dechert’s Global Life Sciences Practice, counsels established and start-up clients in all sectors of the biotech and pharmaceutical industries on developing intellectual property issues, policies, patent portfolio management and filing strategies at all phases of the business cycle. Ms. Reid’s ability to develop IP strategies for U.S. and European clients has resulted in more than US$11 billion in acquisition and investor/partner funding. With more than 30 years of experience working in the pharmaceutical industry, she has extensive experience in all areas of drug discovery through drug development. She draws on this experience when prosecuting patent applications and preparing patentability, validity and infringement opinions involving active pharmaceutical ingredients, manufacturing syntheses and formulations. She regularly represents clients on specialty issues relating to organic chemistry, small molecule pharmaceuticals and polymorph intellectual property.

Sought for her unique breadth of knowledge, Ms. Reid advises patent litigators on technical scientific concepts in complex pharmaceutical patent maters. Additionally, she represents clients in intellectual property due diligence issues and assesses matters connected to in-license and acquisition opportunities.

In 2019, Ms. Reid was selected to serve on the Life Sciences Law360’s Editorial Board as an official life sciences resource for Law360 editorial staff. In 2018, the Financial Times highly commended Ms. Reid’s work for developing the innovative IP strategy that underpinned drug discoverer Nimbus Therapeutics’ novel agreement with Celgene Corporation. Similarly, in 2016, the Financial Times honored Ms. Reid as one of just 10 individuals shortlisted as "Legal Innovator of the Year." She also won the "Legal Expertise" category entitled "Enabling Clients to Innovate" for her work on behalf of Nimbus. Ms. Reid was recognized by The Legal 500 US (2017, 2018, 2019) for Industry focus: Healthcare: Life Sciences, and named among the Top Women of Law in 2017 by the Massachusetts Lawyers Weekly.

Ms. Reid is listed among the Top 250 Women in IP by Managing Intellectual Property, and was recently recognized as an “IP Star” by the same publication. She is routinely named a Massachusetts Super Lawyers Rising Star and a World’s Leading Patent Practitioner by IAM Patent 1000, who referred to her as a “consummate strategist” and "a savior for start-ups" for her ability to “draw on a quarter century’s worth of experience in pharmaceuticals [when providing] sage guidance across the patent lifecycle.”

Prior to joining Dechert, Ms. Reid served as an intellectual property partner at a Boston based law firm. Her previous experience also includes working as a patent agent at a global biotechnology company where she prepared and prosecuted small molecule patent applications for the Protein Kinase gene family and bacterial Gyrase programs. Ms. Reid also worked as a chemist for 14 years in which time she completed several natural product syntheses, worked as both a medicinal and process chemist, was an inventor on 14 United States Patents and co-author of numerous scientific publications.

Education
  • Boston University, B.S., Chemistry, 1987
  • University of Massachusetts Lowell, M.S., Chemistry, 1996
  • Suffolk University Law School, J.D., Intellectual Property, 2006, with distinction
Admissions
  • Massachusetts
  • Supreme Court of the United States
  • United States District Court for the District of Massachusetts
  • United States Patent and Trademark Office
Memberships
  • American Chemical Society
  • Boston IP Inn of Court 
  • Boston Patent Law Association 
  • W.I.T.H Association - Women Innovating Together in Healthcare
Speaking Engagements
  • Life-Sciences Patent Network North America: Protecting Innovation in a Changing Landscape, Boston, MA (April 26, 2018)
  • Managing Intellectual Property U.S. Patent Forum 2018, New York (March 13, 2018)
  • 3rd Drug Discovery Re-Invented Conference — Emerging Role of Biotechs, Academics and Non-Profits, Cancun, Mexico (February 21, 2017)
  • Life Sciences Forum 2016 — Organized by Managing Intellectual Property, New York (September 14, 2016)
  • Recent Developments in Obviousness - A Pharma Perspective — Recent Developments in Intellectual Property Law Seminar, Munich (September 22, 2015)
  • Patent Ruling Leaves Lingering Questions on License Agreements — Suffolk University Law School, Boston, MA (February 1, 2014)
  • Have Prometheus & Myriad Changed the World? — Harvard Business School, Cambridge, MA (October 1, 2013)
  • American Invents Act — Wallinger Ricker Schlotter Tostmann Client Seminar, Munich, Germany (September 1, 2013)
  • Intellectual Property Advisor for the Blavatnik Fellowship — Harvard Business School, Cambridge, MA (January 1, 2013)
  • US Patent Prosecution: Best Practices — Wallinger Ricker Schlotter Tostmann Client Seminar, Munich, Germany (September 1, 2011)
  • Commercializing Technology — Harvard Business School, Cambridge, MA (January 1, 2011)
  • Intellectual Property for Chemists: Feed Your Inner Geek — Northeastern Section ACS, Boston, MA (February 1, 2010)
  • How Changes in Patent Law Alter Patent Prosecution, Litigation and Licensing — Boston Patent Law Association and Suffolk University Law School, Boston, MA (September 1, 2009)
  • A Change in Climate: IP Strategies for Crystal Forms in View of Recent Changes in US Patent Law — IQPC Conference, London, United Kingdom (December 1, 2007)